Archives
-
ATS-9R for Targeted Gene Silencing in Adipocytes
2026-09-17
ATS-9R combines Prohibitin recognition with nona-arginine-mediated nucleic acid condensation for targeted delivery to white adipose tissue. This workflow supports gene silencing in adipocytes and adipose tissue macrophages while providing practical controls for formulation, tissue distribution, and metabolic readouts.
-
Ribonuclease R Workflow for Circular RNA Studies
2026-09-16
Learn how topology-selective RNA digestion can enrich circular transcripts for validation, sequencing, and mechanistic studies. This workflow pairs Ribonuclease R with no-enzyme controls and orthogonal assays so RNase resistance is interpreted as evidence—not proof—of circularity.
-
ML216: From BLM Inhibition to Assay Design
2026-09-16
ML216, a BLM helicase inhibitor, can reveal how DNA repair dependencies shape cellular phenotypes. This article connects biochemical target engagement with BLM-proficient controls, orthogonal readouts, and the interpretive limits of translating RecQ-helicase findings into cancer models.
-
Biotin-XX Tyramide Reagent: Practical Guide
2026-09-15
Learn how Biotin-XX Tyramide Reagent, SKU A8012, can improve localized signal amplification and cell-surface protein labeling in demanding assay workflows. This scenario-based guide covers membrane selectivity, compatibility, optimization, interpretation, and practical supplier-selection criteria.
-
Separating Growth Arrest from Cell Death in Cancer Assays
2026-09-15
Hannah R. Schwartz’s dissertation identifies a critical interpretive problem in anticancer drug testing: relative viability and fractional viability are often treated as interchangeable even though they measure different biological outcomes. Its framework encourages researchers to separate proliferation arrest from cell killing, improving time-course interpretation, assay selection, and translation across cancer models.
-
Canagliflozin and Proximal Tubule Mitochondria
2026-09-14
Explore how Canagliflozin links SGLT2 inhibition with proximal-tubule mitochondrial remodeling. This article translates recent hypertensive-diabetic mouse findings into practical decisions for renal, metabolic, and bioenergetic research.
-
NMDA (N-Methyl-D-aspartic acid) Research Guide
2026-09-14
NMDA (N-Methyl-D-aspartic acid) is a direct NMDA receptor agonist used to model receptor-driven excitotoxic injury. This guide connects its chemical handling, calcium influx measurement, oxidative stress readouts, and use in NMDA-induced glaucoma models.
-
BCA Protein Assay Kit: Reliable Cell Assays
2026-09-13
Learn how the BCA Protein Assay Kit, SKU K4101, supports reproducible protein concentration measurement in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects assay principles, protocol decisions, interpretation, and vendor selection to practical laboratory needs.
-
Doxycycline Hyclate in MMP Research
2026-09-12
Doxycycline hyclate provides a practical way to connect MMP activity with blood–brain barrier failure, neuronal injury, and vascular inflammation. This workflow-centered guide explains how to prepare, apply, validate, and troubleshoot the compound across neurovascular and selected infectious-disease models.
-
PDHA1 Succinylation and α-KGA in Cholangiocarcinoma
2026-09-11
A 2025 Nature Communications study identifies PDHA1 lysine 83 succinylation as a metabolic switch that increases alpha-ketoglutaric acid in the cholangiocarcinoma microenvironment. The resulting OXGR1–MAPK signal suppresses macrophage MHC-II antigen presentation, while pharmacological pathway inhibition improves gemcitabine–cisplatin activity in preclinical models.
-
PTSD Heart–Brain Dysregulation in Mice
2026-09-11
A 2026 European Journal of Pharmacology study identifies a vagus-mediated heart-to-insula pathway linking sympathetic cardiac overactivation with PTSD-like behavior in mice. Its combination of isoproterenol challenge, vagotomy, electrophysiology, and propranolol treatment offers a useful framework for testing causal heart–brain interactions.
-
Doxycycline hyclate for BBB Research
2026-09-10
Doxycycline hyclate is a practical matrix metalloproteinases inhibitor for connecting MMP-2/MMP-9 activity with blood–brain barrier failure, neuronal apoptosis, and behavioral change. This guide translates a mouse arsenic-exposure study into reproducible preparation, assay-selection, troubleshooting, and cross-domain research workflows.
-
Telatinib (BAY 57-9352) Assay Workflows
2026-09-10
Telatinib (BAY 57-9352) supports mechanism-aware studies spanning VEGFR signaling, tumor-cell invasion, proliferation, and endothelial tube formation. This guide translates its multi-kinase profile into practical dose design, combination testing, troubleshooting, and phenotype-focused workflows.
-
EdU Imaging Kits (488) for NSCLC Proliferation
2026-09-09
Translate S-phase DNA synthesis into a clean, image-ready proliferation readout for cancer, cell-cycle, and pharmacology studies. EdU Imaging Kits (488) combine denaturation-free click chemistry with fluorescence microscopy or flow cytometry, helping preserve morphology and antigen accessibility.
-
WRN Loss, p53/PUMA, and MSI Colorectal Cancer
2026-09-09
This PNAS study explains how WRN helicase loss selectively kills mismatch repair-deficient, microsatellite-instable colorectal cancer cells through a p53/PUMA apoptotic program. Its genetic rescue experiments and xenograft data connect synthetic lethality to a defined tumor-suppressor pathway while identifying p53 status as an important determinant of response.